Covestor’s Zevra Therapeutics ZVRA Stock Holding History

Covestor’s Portfolio ZVRA Stock Details ZVRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-56	Closed	-$1K	–	2909
2026 Q2	$1K	Buy	56 +34	+155%	+$378	﹤0.01%	2400
2026 Q1	$0	Buy	+22	New	+$198	﹤0.01%	2847

Other funds holding ZVRA

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Integrity Alliance Urbandale, Iowa $3.28B AUM 15.79% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Retirement Planning Company of New England Warwick, Rhode Island $263M AUM 26.23% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

MAM

Mystic Asset Management Warwick, Rhode Island $451M AUM 22.13% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Covestor's ZVRA Position: Q3 2026 in Review

Covestor sold out of Zevra Therapeutics (ZVRA) in Q3 2026, closing a stake of 56 shares — an estimated $1K sold.

Covestor first reported a position in ZVRA in Q1 2026 and held it in 2 quarters. The position peaked at $1K in Q2 2026. 59 funds tracked by Wall St. Rank hold ZVRA as of Q3 2026.

Covestor reported no remaining Zevra Therapeutics position as of Q3 2026 after selling out during the quarter.
Covestor sold 56 Zevra Therapeutics shares in Q3 2026, an estimated $1K.
Covestor first reported a position in Zevra Therapeutics in Q1 2026 and held it in 2 quarters.
Covestor's Zevra Therapeutics position peaked at $1K in Q2 2026.
59 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.